JP2006096734A5 - - Google Patents

Download PDF

Info

Publication number
JP2006096734A5
JP2006096734A5 JP2004315009A JP2004315009A JP2006096734A5 JP 2006096734 A5 JP2006096734 A5 JP 2006096734A5 JP 2004315009 A JP2004315009 A JP 2004315009A JP 2004315009 A JP2004315009 A JP 2004315009A JP 2006096734 A5 JP2006096734 A5 JP 2006096734A5
Authority
JP
Japan
Prior art keywords
hydrogen
alkyl
formula
alkoxy
cycloalkyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2004315009A
Other languages
English (en)
Japanese (ja)
Other versions
JP2006096734A (ja
JP4976649B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority to AU2005201855A priority Critical patent/AU2005201855B2/en
Priority to CA 2506238 priority patent/CA2506238C/en
Priority to NZ553835A priority patent/NZ553835A/en
Priority to ES05787045T priority patent/ES2431045T3/es
Priority to CN2005800380156A priority patent/CN101094844B/zh
Priority to US11/230,505 priority patent/US8080675B2/en
Priority to PCT/AU2005/001436 priority patent/WO2006032086A1/en
Priority to MX2007003215A priority patent/MX2007003215A/es
Priority to EP11180383.9A priority patent/EP2436680B1/en
Priority to EP05787045.3A priority patent/EP1809618B1/en
Priority to ES11180383.9T priority patent/ES2586847T3/es
Publication of JP2006096734A publication Critical patent/JP2006096734A/ja
Priority to IL182042A priority patent/IL182042A/en
Priority to NO20071578A priority patent/NO20071578L/no
Priority to HK08101549.6A priority patent/HK1112617A1/xx
Publication of JP2006096734A5 publication Critical patent/JP2006096734A5/ja
Priority to US13/231,794 priority patent/US8163795B2/en
Priority to US13/415,697 priority patent/US8461361B2/en
Application granted granted Critical
Publication of JP4976649B2 publication Critical patent/JP4976649B2/ja
Priority to US13/891,975 priority patent/US8957109B2/en
Priority to US14/589,941 priority patent/US9198895B2/en
Priority to US14/922,472 priority patent/US20160136129A1/en
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2004315009A 2004-09-21 2004-10-29 化合物 Expired - Fee Related JP4976649B2 (ja)

Priority Applications (19)

Application Number Priority Date Filing Date Title
CA 2506238 CA2506238C (en) 2004-09-21 2005-05-03 Chroman derived compounds & formulations thereof for use in therapy
AU2005201855A AU2005201855B2 (en) 2004-09-21 2005-05-03 Chroman derived compounds and formulations thereof for use in therapy
ES05787045T ES2431045T3 (es) 2004-09-21 2005-09-21 Derivados de cromano, medicamentos y uso terapéutico
CN2005800380156A CN101094844B (zh) 2004-09-21 2005-09-21 苯并二氢吡喃衍生物，药物及其在治疗中的应用
US11/230,505 US8080675B2 (en) 2004-09-21 2005-09-21 Chroman derivatives, medicaments and use in therapy
PCT/AU2005/001436 WO2006032086A1 (en) 2004-09-21 2005-09-21 Chroman derivatives, medicaments and use in therapy
MX2007003215A MX2007003215A (es) 2004-09-21 2005-09-21 Cromaderivados, medicamentos y su uso en terapias.
EP11180383.9A EP2436680B1 (en) 2004-09-21 2005-09-21 Chroman derivatives, medicaments and use in therapy
EP05787045.3A EP1809618B1 (en) 2004-09-21 2005-09-21 Chroman derivatives, medicaments and use in therapy
ES11180383.9T ES2586847T3 (es) 2004-09-21 2005-09-21 Derivados de cromano, medicamentos y uso terapéutico
NZ553835A NZ553835A (en) 2004-09-21 2005-09-21 7-hydroxy-3,4-diphenyl-chroman derivatives
IL182042A IL182042A (en) 2004-09-21 2007-03-20 Chroman derivatives, medicaments and use in therapy
NO20071578A NO20071578L (no) 2004-09-21 2007-03-26 Kromanderivater, legemidler og anvendelse i terapi
HK08101549.6A HK1112617A1 (en) 2004-09-21 2008-02-12 Chroman derivatives, medicaments and use in therapy
US13/231,794 US8163795B2 (en) 2004-09-21 2011-09-13 Chroman derivatives, medicaments and use in therapy
US13/415,697 US8461361B2 (en) 2004-09-21 2012-03-08 Chroman derivatives, medicaments and use in therapy
US13/891,975 US8957109B2 (en) 2004-09-21 2013-05-10 Chroman derivatives, medicaments and use in therapy
US14/589,941 US9198895B2 (en) 2004-09-21 2015-01-05 Chroman derivatives, medicaments and use in therapy
US14/922,472 US20160136129A1 (en) 2004-09-21 2015-10-26 Chroman derivatives, medicaments and use in therapy

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US61129904P 2004-09-21 2004-09-21
US60/611299 2004-09-21

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2012040002A Division JP2012144537A (ja) 2004-09-21 2012-02-27 化合物

Publications (3)

Publication Number Publication Date
JP2006096734A JP2006096734A (ja) 2006-04-13
JP2006096734A5 true JP2006096734A5 (pt) 2008-02-28
JP4976649B2 JP4976649B2 (ja) 2012-07-18

Family

ID=34956540

Family Applications (3)

Application Number Title Priority Date Filing Date
JP2004315009A Expired - Fee Related JP4976649B2 (ja) 2004-09-21 2004-10-29 化合物
JP2012040002A Pending JP2012144537A (ja) 2004-09-21 2012-02-27 化合物
JP2014104217A Expired - Fee Related JP5816868B2 (ja) 2004-09-21 2014-05-20 化合物

Family Applications After (2)

Application Number Title Priority Date Filing Date
JP2012040002A Pending JP2012144537A (ja) 2004-09-21 2012-02-27 化合物
JP2014104217A Expired - Fee Related JP5816868B2 (ja) 2004-09-21 2014-05-20 化合物

Country Status (2)

Country Link
JP (3) JP4976649B2 (pt)
CN (1) CN101094844B (pt)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2407462B1 (en) 2004-09-21 2014-07-30 Marshall Edwards, Inc. Substituted chroman derivatives, medicaments and use in therapy
US8080675B2 (en) 2004-09-21 2011-12-20 Marshall Edwards, Inc. Chroman derivatives, medicaments and use in therapy
JP4976649B2 (ja) * 2004-09-21 2012-07-18 マーシャル エドワーズ，インク． 化合物
CA2816319C (en) * 2010-11-01 2020-06-30 Marshall Edwards, Inc. Isoflavonoid compounds and methods for the treatment of cancer
CN103224481A (zh) * 2013-05-20 2013-07-31 黑龙江大学 一种去氢雌马酚的制备方法
PT2953938T (pt) * 2014-02-07 2017-10-09 Novogen ltd Compostos de benzopirano funcionais e sua utilização
JP6218680B2 (ja) * 2014-06-11 2017-10-25 三菱電機株式会社 ネットワーク解析支援装置、ネットワーク解析支援方法、および、プログラム
PT3253208T (pt) 2015-02-02 2021-06-17 The Spanish National Cancer Res Centre Terapêuticas de combinação para utilização no tratamento do cancro da mama
CN108409701B (zh) * 2017-02-10 2020-09-25 山东康迈祺生物科技有限公司 一种二氢大豆苷元的制备方法
CN112920173A (zh) * 2021-01-25 2021-06-08 江苏师范大学 一种手性苯并二氢吡喃化合物及其合成方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5883118A (en) * 1996-01-11 1999-03-16 Nova Nordisk A/S Prostatic carcinoma
IL129623A0 (en) * 1996-10-28 2000-02-29 Novo Nordisk As Novel trans-3,4-chroman derivatives useful in the prevention or treatment of estrogen related diseases or syndromes
DK0937062T3 (da) * 1996-10-28 2003-04-07 Novo Nordisk As Nye cis-3,4-chroman-derivater, der er nyttige i forebyggelsen eller behandlingen af østrogen-relaterede sygdomme eller syndromer
KR20000001793A (ko) * 1998-06-13 2000-01-15 이경하 신규한 벤조피란 또는 티오벤조피란 유도체
DK1355906T3 (da) * 2001-01-24 2005-05-30 Chiesi Farma Spa 2H-1-benzopyranderivater, fremgangsmåder til deres fremstilling og farmaceutiske sammensætninger indeholdende dem
JP4976649B2 (ja) * 2004-09-21 2012-07-18 マーシャル エドワーズ，インク． 化合物

Similar Documents

Publication Publication Date Title
JP2012144537A5 (pt)
JP2008502694A (ja) ボリン酸錯体の抗ウイルス使用
JP2002511406A (ja) 感染症の治療および予防処置のための有機リン化合物の使用
JP2010530881A5 (pt)
JP2002513793A5 (pt)
JP2006096734A5 (pt)
EP2308828A3 (en) CaSR antagonist
JP2005536503A5 (pt)
JP2004502732A5 (pt)
JP2003503449A5 (pt)
JP2004529172A5 (pt)
FI91156B (fi) Menetelmä uusien terapeuttisesti käyttökelpoisten neplanosiinijohdannaisten valmistamiseksi
US4658063A (en) Isoprenylamine derivatives
GB2075499A (en) Nonaprenylamine derivatives
US7067666B2 (en) 7-substituted camptothecin and camptothecin analogs and methods for producing the same
JPS6251261B2 (pt)
US4755601A (en) Nonyl prenyl-N heterocyclics
US4322555A (en) Nonaprenylamine derivatives
JPH0128736B2 (pt)
JP2520244B2 (ja) 弗素化ジアミノアルキン誘導体
CA2452920A1 (en) Benzo [g] quinoline derivatives for treating glaucoma and myopia
JPH0128738B2 (pt)
JPWO2005004868A1 (ja) 抗コロナウイルス剤
US4380668A (en) Decaprenylamine derivatives
US4393209A (en) Decaprenylamine derivatives